Close

Cerulean Pharma IPO Info

Company Name: Cerulean Pharma
Stock Symbol: CERU
Exchange: NASDAQ
Status: Priced
IPO Date: 4/10/2014
IPO Price: 7.00 (-11.14%)
Underwriters
Leerink Partners

Amount of Offering: N/A
Number of Shares Offered: 8.5 Mil
Shares Outstanding After Offering: N/A
Valuation: N/A
Company Description
Cerulean Pharma Inc. is a clinical-stage oncology-focused company applying its proprietary Dynamic Tumor Targeting™ platform to develop differentiated therapies. The Company's nanopharmaceutical product candidates consist of proprietary polymers that are covalently linked to anti-cancer therapeutics. The Company's technology platform can be also applied to a wide range of drug molecules, ranging from small molecules to peptides and RNAs. Cerulean is located in Cambridge, Massachusetts.

News Headlines